Published in J Neuropsychiatry Clin Neurosci on January 01, 2005
Performance level modulates adult age differences in brain activation during spatial working memory. Proc Natl Acad Sci U S A (2009) 1.25
Monitoring the mind: the neurocognitive correlates of metamemory. PLoS One (2012) 0.83
A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms. Front Aging Neurosci (2014) 0.82
An exploratory study of the effects of spatial working-memory load on prefrontal activation in low- and high-performing elderly. Front Aging Neurosci (2014) 0.76
Disruption of large-scale brain systems in advanced aging. Neuron (2007) 8.12
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol (2012) 3.19
Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry (2012) 2.94
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81
Brain aging: reorganizing discoveries about the aging mind. Curr Opin Neurobiol (2005) 2.58
Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One (2011) 2.30
Age differences in deactivation: a link to cognitive control? J Cogn Neurosci (2007) 2.14
Viewing facial expressions of pain engages cortical areas involved in the direct experience of pain. Neuroimage (2005) 2.10
A multifactorial approach to understanding fall risk in older people. J Am Geriatr Soc (2010) 1.97
Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy (2003) 1.93
Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry (2006) 1.92
Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol (2008) 1.92
Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology (2003) 1.87
Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology (2007) 1.77
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology (2012) 1.74
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry (2010) 1.72
Evidence for frontally mediated controlled processing differences in older adults. Cereb Cortex (2006) 1.65
Discrete neuroanatomical networks are associated with specific cognitive abilities in old age. J Neurosci (2011) 1.61
Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not? Geriatrics (2005) 1.52
Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness. J Am Geriatr Soc (2004) 1.49
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43
Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment. J Neurol Neurosurg Psychiatry (2010) 1.41
Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders. Front Psychiatry (2013) 1.40
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry (2003) 1.40
Mild cognitive impairment: evaluation with 4-T functional MR imaging. Radiology (2006) 1.37
Regulatory interaction of phosducin-like protein with the cytosolic chaperonin complex. Proc Natl Acad Sci U S A (2002) 1.35
Pharmacovigilance in the 21st century: new systematic tools for an old problem. Pharmacotherapy (2004) 1.33
Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports. Pharmacotherapy (2003) 1.32
The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr (2010) 1.32
Rats and humans paying attention: cross-species task development for translational research. Neuropsychology (2008) 1.32
Opening the KcsA K+ channel: tryptophan scanning and complementation analysis lead to mutants with altered gating. Biochemistry (2002) 1.28
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Dis Assoc Disord (2013) 1.28
Prognostic value of posteromedial cortex deactivation in mild cognitive impairment. PLoS One (2007) 1.28
Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. J Neurosci (2011) 1.24
Olanzapine-associated diabetes mellitus. Pharmacotherapy (2002) 1.24
Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. Psychosom Med (2007) 1.22
Ovary-containing hernia in a premature infant: sonographic diagnosis. J Ultrasound Med (2007) 1.21
CNTRICS final task selection: control of attention. Schizophr Bull (2009) 1.21
Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage (2010) 1.20
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy (2006) 1.20
Who benefits from memory training? Psychol Sci (2007) 1.19
Current status of metals as therapeutic targets in Alzheimer's disease. J Am Geriatr Soc (2003) 1.14
Selective attention supports working memory maintenance by modulating perceptual processing of distractors. J Cogn Neurosci (2007) 1.14
The relationship of neuropsychological function to instrumental activities of daily living in mild cognitive impairment. Int J Geriatr Psychiatry (2010) 1.11
Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial. Am J Med Genet A (2003) 1.10
Marked increase in Alzheimer's disease identified in medicare claims records between 1991 and 1999. J Gerontol A Biol Sci Med Sci (2004) 1.09
Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. Psychosom Med (2010) 1.09
Frontal white matter anisotropy and antidepressant remission in late-life depression. PLoS One (2008) 1.09
Diffusion tensor imaging of the posterior cingulate is a useful biomarker of mild cognitive impairment. Am J Geriatr Psychiatry (2009) 1.08
Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: converging electrochemical and fMRI evidence from rats and humans. J Neurosci (2013) 1.08
Deterministic functions of cortical acetylcholine. Eur J Neurosci (2014) 1.07
Effect of different impairment criteria on prevalence of “objective” mild cognitive impairment in a community sample. Am J Geriatr Psychiatry (2010) 1.06
Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve. Neurobiol Aging (2006) 1.05
Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. J Clin Psychiatry (2008) 1.05
Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012. BMJ (2013) 1.03
Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Alzheimers Dement (2012) 1.02
Metabolomic changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement (2010) 1.02
Does meditation enhance cognition and brain plasticity? Ann N Y Acad Sci (2009) 1.02
Elevation in plasma Abeta42 in geriatric depression: a pilot study. Neurochem Res (2006) 1.02
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues. Clin Trials (2007) 1.01
Long-term memory for the terrorist attack of September 11: flashbulb memories, event memories, and the factors that influence their retention. J Exp Psychol Gen (2009) 1.00
The greyscales task: a perceptual measure of attentional bias following unilateral hemispheric damage. Neuropsychologia (2004) 0.99
Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study. J Am Geriatr Soc (2011) 0.99
The largest human cognitive performance dataset reveals insights into the effects of lifestyle factors and aging. Front Hum Neurosci (2013) 0.99
Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis. Psychopharmacol Bull (2009) 0.98
Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. Arch Neurol (2006) 0.98
Drought induces spruce beetle (Dendroctonus rufipennis) outbreaks across northwestern Colorado. Ecology (2014) 0.98
Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Neuropharmacology (2010) 0.97
Delivering happiness: translating positive psychology intervention research for treating major and minor depressive disorders. J Altern Complement Med (2011) 0.97
Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: evidence from a translational Sustained Attention Task. Schizophr Res (2013) 0.96
CNTRICS final biomarker selection: Control of attention. Schizophr Bull (2011) 0.96
Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study. PLoS One (2013) 0.96
Screening for Early Alzheimer's Disease: Is There Still a Role for the Mini-Mental State Examination? Prim Care Companion J Clin Psychiatry (2005) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. CNS Spectr (2004) 0.95
Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study. PLoS One (2013) 0.95
Risk profiles for mild cognitive impairment vary by age and sex: the Sydney Memory and Ageing study. Am J Geriatr Psychiatry (2012) 0.94
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. J Neuropathol Exp Neurol (2014) 0.94
Investigating the impact of mindfulness meditation training on working memory: a mathematical modeling approach. Cogn Affect Behav Neurosci (2011) 0.93
Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. Am J Med Genet A (2004) 0.92
Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study. J Clin Psychiatry (2007) 0.91
Intima-media thickness and age of first depressive episode. Biol Psychol (2008) 0.91
Accuracy of spatial normalization of the hippocampus: implications for fMRI research in memory disorders. Neuroimage (2006) 0.91
Exercise fails to improve neurocognition in depressed middle-aged and older adults. Med Sci Sports Exerc (2008) 0.91
Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack. Neuroimage Clin (2013) 0.91
Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset. Am J Geriatr Psychiatry (2012) 0.90
A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. J Clin Psychiatry (2004) 0.89
Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study. J Child Adolesc Psychopharmacol (2006) 0.89
Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure. Health Psychol (2002) 0.89
A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. Neuropsychopharmacology (2004) 0.89
Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. J Clin Psychiatry (2014) 0.89
Temporal characteristics of top-down modulations during working memory maintenance: an event-related potential study of the N170 component. J Cogn Neurosci (2007) 0.88
Neuropsychiatric symptoms in older people with and without cognitive impairment. J Alzheimers Dis (2012) 0.88